జుబిరా సివి 20 క్యాప్సూల్ 15's

Drug-Drug Interactions

Before taking Jubira CV 20 Capsule , inform your doctor about all medications, supplements, and herbal products you use, as several medicines can increase the risk of side effects or alter how this combination works.

• Blood thinners (like warfarin): Combining Jubira CV 20 Capsule with anticoagulants can significantly increase the risk of bleeding and bruising.
• Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen: Taking these medicines together may increase the risk of stomach irritation, ulcers, and gastrointestinal bleeding.
• Certain antidepressants (such as SSRIs): These medications can further increase the risk of bleeding when used alongside clopidogrel.
• HIV, hepatitis C, or antifungal medications: Some of these medicines can increase rosuvastatin levels in the body, raising the risk of muscle damage and other side effects.
• Certain stomach acid medicines (such as omeprazole): Some medicines can reduce the activation of clopidogrel in the body, potentially making it less effective. Always check with your doctor before starting new medications. 

Drug-Food Interactions

Certain foods and beverages may affect the safety or effectiveness of Jubira CV 20 Capsule . Keep the following precautions in mind:

• Grapefruit and grapefruit juice: Grapefruit interactions are much more significant with certain statins that are metabolised through the CYP3A4 enzyme system. Rosuvastatin is minimally affected by grapefruit in most patients. Routine avoidance is generally not required, but patients should consult their doctor or pharmacist if they regularly consume grapefruit or take multiple medications.
• Excessive alcohol consumption: Drinking large amounts of alcohol may increase the risk of liver problems and should be avoided or limited while taking this medication.

Drug-Disease Interactions

Certain medical conditions can affect whether Jubira CV 20 Capsule is suitable for you. Make sure your healthcare provider is aware of your complete medical history before starting treatment.

• Active liver disease: This medication should not be used in patients with active liver disease, as it may worsen liver function.
• Kidney impairment: Patients with moderate to severe kidney disease may require dose adjustments and closer monitoring, particularly because rosuvastatin exposure can increase in severe renal impairment. Your doctor will determine the appropriate dose based on your kidney function.
• Active internal bleeding: Conditions such as a bleeding stomach ulcer or other active bleeding disorders make this medication unsafe because clopidogrel reduces blood clotting.
• Thyroid disorders: Patients with uncontrolled thyroid conditions may have a higher risk of muscle-related side effects associated with rosuvastatin.
• History of muscle disorders: Individuals with previous muscle problems or statin-associated muscle symptoms should use this medication with caution and under medical supervision.